Fortune Brands Innovations (FBIN) came out with quarterly earnings of $0.66 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.83 per share a year ago.

Jack Henry (JKHY) came out with quarterly earnings of $1.52 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.19 per share a year ago.

The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.

Day One Biopharmaceuticals, Inc. (DAWN) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.72 per share a year ago.

LUXEMBOURG, May 06, 2025 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) announced that its annual general meeting of shareholders and extraordinary general meeting of shareholders, both held on May 6, 2025, approved all resolutions on their agendas.

Arista Networks (ANET) posted better-than-expected earnings as quarterly revenue reached a record high.

WW International (WW) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.06 per share a year ago.

Super Micro Computer (SMCI) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.30 per share. This compares to earnings of $0.67 per share a year ago.

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of $1.68 per share, missing the Zacks Consensus Estimate of $4.51 per share. This compares to earnings of $2.68 per share a year ago.

Arista Networks (ANET) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.50 per share a year ago.

Lyra Therapeutics, Inc. (LYRA) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.35 per share a year ago.

NEW YORK--(BUSINESS WIRE)---- $TWO #TWO--TWO Announces Pricing of Public Offering of Senior Notes.

Nebius Group N.V.'s aggressive GPU deployment (22k Blackwell GPUs) and timely Kansas City data-center launch will confirm operational strength. Execution here is pivotal for reaching ~$1B ARR by late 2025. Robust $2.4B cash reserve and minimal debt give Nebius flexibility to scale rapidly despite very high capex. Strategic Nvidia partnership significantly reduces execution and chip supply risks. With AI infrastructure spending doubling recently and TAM growing at ~35% CAGR, NBIS stock's current price ($25) deeply undervalues potential; my $55 target anticipates strong margin improvement into 2026.

LEXINGTON, Mass. , May 6, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Board of Directors of Curis approved the grant of inducement stock options to its newly appointed Chief Medical Officer, Dr. Ahmed Hamdy to purchase 200,000 shares of Curis common stock, with a grant date of May 1, 2025 (the "Inducement Grant").

Devon Energy (DVN) came out with quarterly earnings of $1.21 per share, missing the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.16 per share a year ago.

Dynavax Technologies (DVAX) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.07 per share a year ago.

Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.23 per share a year ago.

Redfin (RDFN) came out with a quarterly loss of $0.73 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $0.57 per share a year ago.

Revolve Group (RVLV) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.15 per share a year ago.

Gen Digital (GEN) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.53 per share a year ago.